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In a sixty-seven year old female smoker, a right lower lobe mass, intimately related to the mediastinum,
was detected on computed tomography (CT) scanning. Bronchoscopy conﬁrmed non-small cell lung
cancer (NSCLC) and a subsequent integrated 18F-FDG Positron Emission Tomography (PET)/CT scan
demonstrated a rim of non-FDG avid tissue between the lung tumour and the mediastinum, and no
nodal or distant metastases. The patient was pre-operatively staged as cT3N0M0 and proceeded to
exploratory thoracotomy.
On histological examination of the resected right lower lobe, multiple deposits of bronchioalveolar cell
carcinoma (BAC) were found surrounding a central adenocarcinoma, in addition to a small deposit of
adenocarcinoma in a right upper lobe wedge resection sample. Neither the BAC deposits nor the upper
lobe disease had been detected on integrated FDG-PET/CT scanning.
The ﬁnal pathological staging of this case (pT4N0M1 (stage IV)) is inconsistent with the improved
survival rate of patients with multi-focal intrapulmonary NSCLC conﬁned to the lung over other forms of
T4 or M1 disease, particularly when the BAC cell type is involved. This case highlights these major
limitations of the current TNM classiﬁcation and discusses the increased risk of false negative results
from integrated FDG-PET/CT scanning in the BAC form of NSCLC.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
The diagnosis and pre-operative assessment of multi-focal
intrapulmonary non-small cell lung cancer (NSCLC) poses partic-
ular challenges for the lung cancer multi-disciplinary team. Disease
conﬁned to the lungs, without nodal or distant metastases can
often be treated surgically and a good long-term outcome expected.
This is inconsistent with the current TNM classiﬁcation of NSCLC
which classiﬁes multi-focal NSCLC as stage IIIB (T4 disease:
deposits in the same lobe as the primary) or stage IV (M1 disease;
deposits in a separate lobe), implying a poor long-term survival and
discouraging lung resection surgery.
The case we report highlights this limitation of the current
staging system and discusses particular difﬁculties encountered in
using integrated FDG-PET/CT scanning in the pre-operative
assessment of multi-focal intrapulmonary NSCLC, particularly
when the bronchioalveolar sub-type is involved as in this case.t, Gartnavel General Hospital,
: þ44 141 211 3000; fax: þ44
).2. Case history
A sixty-seven year old female was referred to our unit by the
local pancreato-biliary team following the detection of a right
lower lobe mass on abdominal computed tomography (CT) scan-
ning performed for another reason. The patient was an ex-smoker,
having stopped 4 years ago. When assessed in the respiratory clinic
she described a new non-productive cough but no other symptoms.
Clinical examinationwas unremarkable and herWHO performance
status was estimated at 0.
Review of her recent CT scan demonstrated a 6.5 4.1 cm
pleural-based mass in the right lower lobe which appeared to
encase the medial and inferior aspects of the vascular pedicle of the
right hilum and the inferior pulmonary vein. Therewas no evidence
of mediastinal lymphadenopathy but the appearances were highly
suspicious of direct mediastinal invasion. Standard ﬁbreoptic
bronchoscopy revealed no mucosal abnormality although the
medial basal sub-segment of the right lower lobe appeared exter-
nally compressed. Cytological samples were taken from this sub-
segment by bronchial brush biopsy and saline lavage.Microscopy of
the bronchial aspirate demonstrated several groups of large atyp-
ical cells with pleomorphic nuclei and distinct cytoplasm consistent
with NSCLC. Immunocytochemistry was unhelpful in conﬁrming an
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obstruction (forced expiratory volume in one second 1.55 litres,
65% of predicted) and a corrected diffusion capacity for carbon
monoxide that was 67% of predicted.
The case was discussed at our multi-disciplinary lung cancer
meeting with a view to clarifying the T-staging of the primary
tumour and deciding on the patient’s suitability for surgical treat-
ment. On review of the CT images it remained impossible to
delineate the tumour within the enhancing mass. Since the patient
was otherwise an operable candidate an integrated 18F-FDG Posi-
tron Emission Tomography (PET)/CT scan was arranged to help
clarify the T-staging and screen for mediastinal nodal disease or
distant metastases (see Fig. 1). This revealed intense FDG uptake
(SUV 12.0 g/ml) within the inferolateral aspect of the soft tissue
mass, presumed to represent the viable tumour. However, in the
medial aspect of the mass, adjacent to the left atrium there was
a rim of soft tissue that showed no signiﬁcant FDG activity. This was
presumed to be collapsed lung lying adjacent to the tumour and
separating it from the mediastinum. There was no evidence of
nodal disease or distant metastases. Therefore, the patient was pre-
operatively staged as cT3N0M0 and proceeded to exploratory
thoracotomy.
At thoracotomy a large tumour was found in the right lower
lobe. In keeping with the results of integrated FDG-PET/CT scan-
ning, there was no evidence of mediastinal invasion. However, the
tumour was adherent across the major ﬁssure into the upper lobeFig. 1. An integrated 18F-FDG Positron Emission Tomography/Computerised Tomography (PE
CT imaging. (a) FDG-PET component demonstrating focal avid FDG activity in the right lowe
pleural-based soft tissue mass in the right lower lobe. (c) Integrated FDG-PET/CT image de
presumed to be collapsed lung.and a wedge resection of the adjacent area of the upper lobe was
performed in addition to a right middle and lower bilobectomy.
The patient made an uneventful post-operative recovery and
histology from the resected lung tissue revealed a moderately
differentiated adenocarcinoma located centrally within the visible
tumour mass (see Fig. 2(a)). The periphery of the mass was occu-
pied by bronchioalveolar cell carcinoma (BAC) of mucinous type
and there were several other small foci of BAC some distance from
the primary tumourmass within the right lower lobe (see Fig. 2(b)).
The right upper lobe wedge resection sample showed moderately
differentiated adenocarcinoma with clear resection margins and
the right middle lobe was free of tumour. Neither vascular nor
lymphatic invasion were identiﬁed and all 17 of the lymph-nodes
sampled (right pulmonary artery, hilar and peribronchial nodes)
were negative. Although the surgeon was conﬁdent that the entire
tumour had been removed, she will be considered for adjuvant
therapy given her ﬁnal pathological staging of pT4N0M1 multi-
focal adenocarcinoma/BAC.
3. Discussion
Following FDG-PET/CT scanning this patient was pre-opera-
tively staged as cT3N0M0 and proceeded to exploratory thora-
cotomy with a view to potentially curative surgical resection.
Although there was no evidence of direct mediastinal invasion at
thoracotomy, as shown by the pre-operative FDG-PET/CT scan,T/CT) scan was performed to clarify the T-staging of the tumour visible on conventional
r lobe. (b) Co-registered non-contrast enhanced CT scan demonstrating the 6.5 4.1 cm
monstrating a rim of non-FDG avid tissue between the tumour and the mediastinum,
Fig. 2. (a) Central region of main tumour showing poorly differentiated adenocarcinoma with an acinar pattern (H&E, 40). (b) Periphery of the main tumour showing a bron-
chioalveolar pattern, mucinous type (H&E, 20).
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central tumour mass in the right lower lobe and a deposit of
adenocarcinoma in the right upper lobe.
This case highlights the limitations of the current TNM classi-
ﬁcation of NSCLC when applied to patients with multi-focal intra-
pulmonary NSCLC without nodal or distant metastases. It also
emphasises the relative strengths and weakness of integrated FDG-
PET/CT scanning, which is becoming an increasingly well estab-
lished and widely available part of pre-operative lung cancer
assessment.
3.1. TNM classiﬁcation in multi-focal NSCLC
According to the current TNM classiﬁcation of NSCLC, pulmo-
nary metastases (PM) within the same lobe (described as PM1)
constitute T4 disease (stage IIIB) while PM within a separate lobe
(PM2) constitute metastatic (stage IV) disease. The patient
reported was therefore staged as pT4N0M1. The appropriateness
of this staging approach in this clinical scenario has been debated
recently because most investigators, outside Japan, have demon-
strated greatly improved long-term survival of patients with iso-
lated node-negative PM1 and PM2 disease treated surgically
compared to patients with any other form of T4 and M1 disease.1–
3 This contrast has prompted calls for the down-staging of PM1
(currently T4) lesions to T3 disease and PM2 (currently M1)
lesions to T4 disease in the TNM re-classiﬁcation of NSCLC due in
2009.3
Derivation of useful prognostic information from the current
TNM classiﬁcation becomes even more difﬁcult in multi-focal BAC.
In this context, complete surgical resection is often successful in
patients without nodal or extra-pulmonary disease and the current
NSCLC system does not predict survival. This is illustrated in one
recent surgical series in which a 64% 5-year survival rate was seen
following complete resection, irrespective of whether the disease
was bilateral,4 in which case an M1 staging label would be applied
based on the current TNM system. This label is clearly incongruent
with a long-term survival rate following surgery that approaches
that seen in localised stage 1 or 2 NSCLC of other cell types.
3.2. Integrated FDG-PET/CT scanning
Our case also highlights the relative strengths and weakness of
integrated FDG-PET/CT scanning. It is widely known that the low
spatial resolution of FDG-PET imaging makes the detection of small
deposits of lung cancer (<9 mm in diameter) difﬁcult. Our case
illustrates the well known belief that integrated FDG-PET/CT
scanning provides little additional information over conventional
CT in detecting small metastases. It is perhaps less well known thatPET sensitivity is also affected by tumour type. Studies inwhich this
modality has been used to assess suspicious intrapulmonary
abnormalities have reported a greater risk of false negative results
with adenocarcinoma or BAC, both of which were found in the false
negative areas of lung in the patient described. In one study
reported recently, 65% of the 20 false negative results reported in
a population of nearly 4000 patients (an overall false negative rate
of only 0.5%) were attributed to these cell types.5 The particularly
high false negative rate of BAC is probably due to the lower turn-
over of glucose in this more biologically indolent form of lung
cancer.6
In the case reported, we interpreted the rim of non-FDG avid
tissue surrounding the primary tumour mass on the pre-operative
integrated FDG-PET/CT scan as collapsed lung, separating the
tumour from the mediastinum and excluding T4 disease. This
conclusionwas based on evidence extrapolated from recent reports
of the successful use of integrated FDG-PET/CT scanning as means
of deﬁning tumour volume for radiotherapy treatment planning in
NSCLC.7,8 In retrospect, this area may have represented a truly false
negative result caused by the rim of BAC found around the central
tumour mass on histological examination.
In conclusion, therefore, the patient reported appears to have
received the right operation for multi-focal NSCLC, albeit for the
wrong reasons based on pre-operative staging investigations. This
case highlights the combined difﬁculties in applying the current
TNM classiﬁcation and the results of integrated FDG-PET/CT
imaging in patients with multi-focal intrapulmonary NSCLC
without nodal or distant metastases, especially when the BAC sub-
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